Recent studies have found that oestrogen-only users had decreased odds of being diagnosed with distant disease and that tumours in women having used the combined oestrogen–progestin HRT regimens were more often both oestrogen- and progesterone-receptor positive (Daling et al, 2003; Li et al, 2003). The gene discussed is PGR; the disease is neoplasm.